Caraco Pharma

• Sun Pharma Unit Recalls Mutiple Lots of Capsules From US

  According to a notification by the USFDA, the recall of the 3,40,553 units of 500 mg and 1,13,677 units of 250 mg bottles is voluntarily initiated by the company through a letter to the regulator in June under Class-II classification.

• 

  Sun Pharma Recalls 200 Vials of Cancer Drug: FDA

  The drug being recalled was manufactured by Sun Pharma's unit Caraco Pharmaceutical Laboratories Ltd at its plant in Gujarat, the FDA said in a post on its website.

• 

  Sun Pharma Recalls Over 4 Lakh Bottles of 2 Drugs in US: Report

  Drug major Sun Pharmaceuticals is recalling over 4 lakh bottles of anti-depressant and anti-allergy drugs in the US for failing to meet specifications.

• 

  Sun Pharma to Close Detroit Manufacturing Plant

  Drug major Sun Pharmaceuticals will close its facility at Detroit as part of a manufacturing consolidation process in the US.

• Sun Pharma falls after report about FDA queries

  Sun received two so-called Form 483s, issued when the U.S. regulator has queries, for its Detroit-based Caraco Pharmaceutical Laboratories Ltd following inspections in January and May this year, Bloomberg reported on Monday, citing a Freedom of Information Act request.

• Sun Pharma says issues with US health regulator at Caraco facility addressed

  United States Food and Drug Administration had conducted inspections in January and May this year and had noticed the lapses.

• Sun Pharma shares rise on U.S. acquisition

  Shares in Sun Pharmaceutical Industries, India's most valued drugmaker, rose as much as 2.5 percent after its unit agreed to buy the generic drugs business of U.S.-based URL Pharma from Japan's Takeda Pharmaceutical Co.

• Sun Pharma arm to buy Takeda's US-based generics subsidiary

  Drug major Sun Pharmaceutical Industries today said its arm Caraco Pharma will buy Japanese drug maker Takeda Pharmaceuticals' US-based generics subsidiary URL Pharma.

• Sun Pharma up on US court's diabetes ruling

  Sun Pharmaceutical Industries rose 2.4 per cent after the U.S. Supreme Court allowed the Indian drug maker to sue a brand name rival

• Caraco can sue Novo Nordisk to narrow drug description: US Supreme Court

  Sun Pharma's US subsidiary Caraco can sue Denmark's Novo Nordisk to narrow description of a patented drug.